Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation.

[1]  J. Armitage,et al.  Pilot study of the DHAP rescue protocol and of a new conditioning regimen in responding NHL, at relapse , 1989 .

[2]  D. Weisenburger,et al.  The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  B. Shank,et al.  Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Weisenburger,et al.  Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. , 1988, Blood.

[5]  S. Jagannath,et al.  Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). , 1988, Blood.

[6]  H. Deeg,et al.  Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  K. Anderson,et al.  Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. , 1987, The New England journal of medicine.

[8]  J. Armitage,et al.  High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. , 1987, The New England journal of medicine.

[9]  S. Horning,et al.  Treatment of refractory non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine, and cisplatin. , 1987, Cancer treatment reports.

[10]  H. Ueoka,et al.  Salvage chemotherapy for non-Hodgkin's lymphoma with a combination of mitoxantrone, etoposide, cisplatin, and prednisolone. , 1987, Cancer treatment reports.

[11]  W. Velasquez,et al.  Results of MIME salvage regimen for recurrent or refractory lymphoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Territo,et al.  Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphoma. , 1987, Cancer treatment reports.

[13]  J. Armitage,et al.  High dose therapy and autologous marrow transplantation as salvage treatment for patients with diffuse large cell lymphoma. , 1986, European journal of cancer & clinical oncology.

[14]  J. Armitage,et al.  High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease. , 1986, Annals of internal medicine.

[15]  F. Berger,et al.  Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80). , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Braylan,et al.  Etoposide, carmustine, bleomycin, and methotrexate with leucovorin rescue as re-treatment for unfavorable non-Hodgkin's lymphoma. , 1985, Cancer treatment reports.

[17]  J. Connors,et al.  MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. , 1985, Annals of internal medicine.

[18]  G. Clamon,et al.  Salvage therapy of aggressive non‐Hodgkin's lymphoma with a combination of vinblastine, bleomycin, and cisplatin , 1984, Cancer.

[19]  J. Fay,et al.  Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. , 1984, The New England journal of medicine.

[20]  R. Fisher,et al.  Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. , 1983, Annals of internal medicine.

[21]  G. Pinkus,et al.  Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  F. Cabanillas,et al.  IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. , 1982, Blood.

[23]  M. Pasmantier,et al.  Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen. , 1982, Annals of internal medicine.

[24]  J BERKSON,et al.  Calculation of survival rates for cancer. , 1950, Proceedings of the staff meetings. Mayo Clinic.